SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $63,673,000 | +1094.4% | 368,455 | +694.4% | 0.10% | +1285.7% |
| Q4 2014 | $5,331,000 | -51.2% | 46,380 | -33.6% | 0.01% | -50.0% |
| Q3 2014 | $10,919,000 | +276.6% | 69,884 | +197.4% | 0.01% | +250.0% |
| Q2 2014 | $2,899,000 | -34.3% | 23,500 | -44.8% | 0.00% | -33.3% |
| Q1 2014 | $4,412,000 | -85.0% | 42,584 | -87.0% | 0.01% | -85.0% |
| Q4 2013 | $29,428,000 | +74.7% | 327,195 | +29.9% | 0.04% | +48.1% |
| Q3 2013 | $16,849,000 | -43.3% | 251,930 | -43.9% | 0.03% | -51.8% |
| Q2 2013 | $29,732,000 | – | 449,468 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
| Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
| FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
| Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
| FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
| HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
| Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
| ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
| Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |